<DOC>
	<DOCNO>NCT01533168</DOCNO>
	<brief_summary>RATIONALE : Testing minimal residual disease cell sample patient acute lymphoblastic leukemia may help doctor plan good treatment . PURPOSE : This research trial study genetic test identifying previously undetectable minimal residual disease cell sample young patient acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Genetic Test To Identify Previously Undetectable Minimal Residual Disease Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To identify characterize change clonal population B cell child acute lymphoblastic leukemia ( ALL ) diagnosis Day 29 induction . - To define ability technology reclassify patient minimal residual disease ( MRD ) positive Day 29 induction . - To determine whether sensitive detection MRD Day 29 would clinical prognostic value child ALL . OUTLINE : DNA extract diagnostic cell analyze immunoglobulin heavy chain variable region next-generation sequencing .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Neoplasm , Residual</mesh_term>
	<mesh_term>Immunoglobulin Heavy Chains</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Samples patient enrol COGAALL0232 standardrisk ( SR ) highrisk ( HR ) acute lymphoblastic leukemia ( ALL ) varying level MRD relapse Diagnostic cell Day 29 cell patient relapse 5 year diagnosis protocol COGAALL0232 Diagnostic cell Day 29 cell patient match age , sex , initial white blood cell ( WBC ) count , cytogenetics relapse PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
</DOC>